Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07221266 · ClinicalTrials.gov registry record · NA
Changes in Movement, Fitness, and Quality of Life in People With Parkinson's Disease After Different Exercise Programs
A NA study, sponsored by University of Texas, El Paso.
- Recruiting
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT07221266: Recruiting NA study, sponsored by University of Texas, El Paso.
NCT07221266 is a NA study that is actively recruiting participants, run by University of Texas, El Paso. The registered enrollment target is 45 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07221266, a NA study, is actively recruiting participants, sponsored by University of Texas, El Paso.
- RECRUITING
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
Parkinson's disease (PD) is a progressive neurological condition that can affect movement, balance, endurance, and overall quality of life. Exercise is widely recognized as one of the most effective non-pharmacological treatments to help people with PD maintain function and independence. However, not all exercise programs produce the same results, and more research is needed to understand which types of exercise offer the greatest physical and physiological benefits. This study is designed to examine how different types of structured exercise programs influence motor function, cardiorespiratory fitness, and markers of overall health in individuals with Parkinson's disease. The goal is to better understand how exercise can be used to improve movement, daily activities, and general well-being, as well as how it affects the body at a physiological level. Participants will be adults diagnosed with idiopathic Parkinson's disease who are medically stable and able to safely participate in exercise. Before beginning the study, participants will complete screening procedures to ensure safety and eligibility. Eligible participants will then be assigned to one of several supervised exercise interventions conducted over a defined period. Each exercise program is designed to improve movement and function but differs in structure or training emphasis (for example, aerobic, functional, or task-specific activity). Exercise sessions will take place under the supervision of licensed physical therapist. Each session will include warm-up, exercise, and cool-down components. Intensity will be monitored using heart rate and perceived exertion to ensure safety and appropriate challenge. Participants will attend sessions multiple times per week for 8 weeks. Researchers will collect information about movement abilities, balance, walking, endurance, and daily function using standardized physical therapy assessments such as gait tests, balance measures, and questionnaires related to quali
Primary Outcome
The Mini-Balance Evaluation Systems Test (Mini-BESTest) assesses anticipatory control, reactive postural control, sensory orientation, and dynamic gait. Total score range 0-28; higher scores indicate better balance.
Interventions
- BEHAVIORAL Guided Cycling
- BEHAVIORAL Non-Contact Boxing
- BEHAVIORAL Traditional Physical Therapy Program (Standard of Care)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2026-04-21 |
| Est. Completion | 2027-06-30 |
| Phase | NA |
What NCT07221266 shows while recruiting
NCT07221266 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 3 interventions - of which Guided Cycling is the first listed.
NCT07221266 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07221266 about?
NCT07221266 is a clinical study titled "Changes in Movement, Fitness, and Quality of Life in People With Parkinson's Disease After Different Exercise Programs". Parkinson's disease (PD) is a progressive neurological condition that can affect movement, balance, endurance, and overall quality of life. Exercise is widely recognized as one of the most effective non-pharmacological treatments to help people with PD maintain function and independence. However, no...
What is the current status of trial NCT07221266?
This trial is currently recruiting. It is a NA study. The enrollment target is 45 participants. The study started on 2026-04-21. Estimated completion is 2027-06-30.
What interventions are being tested in trial NCT07221266?
The interventions under investigation include: Guided Cycling (BEHAVIORAL), Non-Contact Boxing (BEHAVIORAL), Traditional Physical Therapy Program (Standard of Care) (BEHAVIORAL).
Who is sponsoring clinical trial NCT07221266?
This trial is sponsored by University of Texas, El Paso, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07221266's enrollment target sits among peer trials
45 1411th of 2000 higher than 578 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI